The University of Chicago Header Logo

Connection

Peng Wang to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Peng Wang has written about Protein Kinase Inhibitors.
Peng Wang
Connection Strength
0.041
Protein Kinase Inhibitors
  1. Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. Haematologica. 2023 08 01; 108(8):2234-2239.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.